Drug Approval for the Treatment of Geographic Atrophy: How We Got Here and Where We Need to Go

To discuss the clinical trial results leading to the FDA approval of anti-complement therapies for geographic atrophy (GA), perspectives on functional data from the GA clinical trials, and how lessons from the FDA approval may guide future directions for basic and clinical research in AMD.
Source: American Journal of Ophthalmology - Category: Opthalmology Authors: Tags: Perspective Source Type: research